KC1086
/ Konruns Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 18, 2025
A Study of KC1086 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=66 | Not yet recruiting | Sponsor: Beijing Konruns Pharmaceutical Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1